Kirkland Advises RLDatix on Merger of its Life Sciences Division with MediSpend to Create New Platform

Advising firms

The announcement does not name individual lawyers.

Want co-counsel patterns, repeat clients and alerts when these firms land their next deal? Get Pro.

Stated terms

Stated value

Not stated

What the figure measures

Not stated

Client

RLDatixSell-side

Counterparties

MediSpend (Buy-side)